Taxonomic group: bacteria / Proteobacteria
(Phylum: Proteobacteria)
Host organism: Homo sapiens
Associated disease: septicemia [ICD11:
MA15.Y 
];
pneumonia [ICD11:
CA40 
];
urinary tract infections (UTI) [ICD11:
GC08 
];
meningitis [ICD11:
1D01 
];
infection due to Acinetobacter baumannii [ICD11:
XN8LS 
]
The structure was elucidated in this paperNCBI PubMed ID: 23782391Publication DOI: 10.1111/mmi.12300Journal NLM ID: 8712028Publisher: Blackwell Publishing
Correspondence: mfeldman

ualberta.ca
Institutions: Alberta Glycomics Centre, Department of Biological Sciences, University of Alberta, Edmonton, AB, Canada
Multi-drug resistant strains of Acinetobacter baumannii are increasingly being isolated in hospitals worldwide. Among the virulence factors identified in this bacterium there is a general O-glycosylation system that appears to be important for biofilm formation and virulence, and the capsular polysaccharide, which is essential for resistance to complement killing. In this work, we identified a locus that is responsible for the synthesis of the O-pentasaccharide found on the glycoproteins. Besides the enzymes required for the assembly of the glycan, additional proteins typically involved in polymerization and transport of capsule were identified within or adjacently to the locus. Mutagenesis of PglC, the initiating glycosyltransferase prevented the synthesis of both glycoproteins and capsule, resulting in abnormal biofilm structures and attenuated virulence in mice. These results, together with the structural analysis of A. baumannii 17978 capsular polysaccharide via NMR, demonstrated that the pentasaccharides that decorate the glycoproteins are also the building blocks for capsule biosynthesis. Two linked subunits, but not longer glycan chains, were detected on proteins via MS. The discovery of a bifurcated pathway for O-glycosylation and capsule synthesis not only provides insight into the biology of A. baumannii but also identifies potential novel candidates for intervention against this emerging pathogen.
Acinetobacter baumannii, capsular polysaccharide, capsule biosynthesis, genetic locus, O-pentasaccharide
Structure type: polymer chemical repeating unit
Location inside paper: p.820
Trivial name: O-glycan
Compound class: CPS
Contained glycoepitopes: IEDB_130648,IEDB_135813,IEDB_136906,IEDB_137340,IEDB_137472,IEDB_137473,IEDB_140529,IEDB_141794,IEDB_141807,IEDB_142488,IEDB_146664,IEDB_151528,IEDB_151531,IEDB_167069,IEDB_190606,IEDB_983931,SB_192,SB_21,SB_7
Methods: 13C NMR, 1H NMR, NMR-2D, SDS-PAGE, DNA techniques, Western blotting, biological assays, microscopy, CID-MS, HILIC-MS
Comments, role: NMR data of the GlcpNAc3NAcA residue 1H: 5.06 3.95 4.23 3.64 3.96 -; 13C: 102.6 54.1 53.8 71.4 77.5 ?.
NCBI Taxonomy refs (TaxIDs): 400667Reference(s) to other database(s): GTC:G64997NS
Show glycosyltransferases
NMR conditions: in D2O at 303 K
[as TSV]
13C NMR data:
Linkage Residue C1 C2 C3 C4 C5 C6
3,6,4,2 Ac
3,6,4,3 Ac
3,6,4,4 Ac
3,6,4 bDGlcpN3NA 102.5 54.5 55.8 72.0 75.2 ?
3,6,6,2 Ac
3,6,6 bDGlcpN 103.0 56.7 75.2 71.0 76.9 61.9
3,6 aDGalp 99.2 68.5 81.7 78.1 70.6 72.3
3 bDGlcp 106.1 74.1 76.8 70.0 75.4 65.8
2 Ac
bDGalpN 104.9 52.6 81.7 69.1 75.9 62.4
1H NMR data:
Linkage Residue H1 H2 H3 H4 H5 H6
3,6,4,2 Ac
3,6,4,3 Ac
3,6,4,4 Ac
3,6,4 bDGlcpN3NA 5.09 3.83 4.03 4.97 4.06 -
3,6,6,2 Ac
3,6,6 bDGlcpN 4.48 3.69 3.54 3.46 3.45 3.78-3.93
3,6 aDGalp 4.93 3.72 3.90 4.35 4.05 3.72-4.07
3 bDGlcp 4.57 3.32 3.49 3.61 3.61 3.65-3.99
2 Ac
bDGalpN 4.62 4.15 3.87 4.16 3.71 3.84
1H/13C HSQC data:
Linkage Residue C1/H1 C2/H2 C3/H3 C4/H4 C5/H5 C6/H6
3,6,4,2 Ac
3,6,4,3 Ac
3,6,4,4 Ac
3,6,4 bDGlcpN3NA 102.5/5.09 54.5/3.83 55.8/4.03 72.0/4.97 75.2/4.06
3,6,6,2 Ac
3,6,6 bDGlcpN 103.0/4.48 56.7/3.69 75.2/3.54 71.0/3.46 76.9/3.45 61.9/3.78-3.93
3,6 aDGalp 99.2/4.93 68.5/3.72 81.7/3.90 78.1/4.35 70.6/4.05 72.3/3.72-4.07
3 bDGlcp 106.1/4.57 74.1/3.32 76.8/3.49 70.0/3.61 75.4/3.61 65.8/3.65-3.99
2 Ac
bDGalpN 104.9/4.62 52.6/4.15 81.7/3.87 69.1/4.16 75.9/3.71 62.4/3.84
1H NMR data:
| Linkage | Residue | H1 | H2 | H3 | H4 | H5 | H6 |
| 3,6,4,2 | Ac | |
| 3,6,4,3 | Ac | |
| 3,6,4,4 | Ac | |
| 3,6,4 | bDGlcpN3NA | 5.09 | 3.83 | 4.03 | 4.97 | 4.06 |
|
| 3,6,6,2 | Ac | |
| 3,6,6 | bDGlcpN | 4.48 | 3.69 | 3.54 | 3.46 | 3.45 | 3.78 3.93 |
| 3,6 | aDGalp | 4.93 | 3.72 | 3.90 | 4.35 | 4.05 | 3.72 4.07 |
| 3 | bDGlcp | 4.57 | 3.32 | 3.49 | 3.61 | 3.61 | 3.65 3.99 |
| 2 | Ac | |
| | bDGalpN | 4.62 | 4.15 | 3.87 | 4.16 | 3.71 | 3.84 |
|
13C NMR data:
| Linkage | Residue | C1 | C2 | C3 | C4 | C5 | C6 |
| 3,6,4,2 | Ac | |
| 3,6,4,3 | Ac | |
| 3,6,4,4 | Ac | |
| 3,6,4 | bDGlcpN3NA | 102.5 | 54.5 | 55.8 | 72.0 | 75.2 | ? |
| 3,6,6,2 | Ac | |
| 3,6,6 | bDGlcpN | 103.0 | 56.7 | 75.2 | 71.0 | 76.9 | 61.9 |
| 3,6 | aDGalp | 99.2 | 68.5 | 81.7 | 78.1 | 70.6 | 72.3 |
| 3 | bDGlcp | 106.1 | 74.1 | 76.8 | 70.0 | 75.4 | 65.8 |
| 2 | Ac | |
| | bDGalpN | 104.9 | 52.6 | 81.7 | 69.1 | 75.9 | 62.4 |
|
 The spectrum also has 1 signal at unknown position (not plotted). |
There is only one chemically distinct structure: